What does Dr.Leroux, oogarts - Dr.Ector, cardioloog do?

Dr.Leroux, oogarts - Dr.Ector, cardioloog is a specialist medical practice in Herent. Private Limited, started on 26 February 2010, 1 establishment.

What is the address of Dr.Leroux, oogarts - Dr.Ector, cardioloog?

The registered office of Dr.Leroux, oogarts - Dr.Ector, cardioloog is located at Schoonzichtlaan 92, 3020 Herent.

Is Dr.Leroux, oogarts - Dr.Ector, cardioloog still active?

Yes. According to the CBE (15 November 2026) Dr.Leroux, oogarts - Dr.Ector, cardioloog is active, legal situation “Normale toestand”, started on 26 February 2010.

Is Dr.Leroux, oogarts - Dr.Ector, cardioloog registered on Peppol?

Yes, Dr.Leroux, oogarts - Dr.Ector, cardioloog is registered on the Peppol network with ID 0208:0823558209.

What is the enterprise number of Dr.Leroux, oogarts - Dr.Ector, cardioloog?

The enterprise number of Dr.Leroux, oogarts - Dr.Ector, cardioloog is BE0823558209.

When was Dr.Leroux, oogarts - Dr.Ector, cardioloog founded?

Dr.Leroux, oogarts - Dr.Ector, cardioloog was founded on 26 February 2010.

Who are the directors of Dr.Leroux, oogarts - Dr.Ector, cardioloog?

According to the 2025 annual accounts, the directors of Dr.Leroux, oogarts - Dr.Ector, cardioloog are: Kathleen Leroux, Bavo Ector.

Is Dr.Leroux, oogarts - Dr.Ector, cardioloog a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 February 2010; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Dr.Leroux, oogarts - Dr.Ector, cardioloog make in 2025?

Dr.Leroux, oogarts - Dr.Ector, cardioloog posted a profit after taxes of € 739,953 in financial year 2025.

What is the revenue of Dr.Leroux, oogarts - Dr.Ector, cardioloog?

As a small company, Dr.Leroux, oogarts - Dr.Ector, cardioloog is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 1,031,489.

Dr.Leroux, oogarts - Dr.Ector, cardioloog (Private Limited)

Dossier Dr.Leroux, oogarts - Dr.Ector, cardioloog, printed on 15 November 2026 from databakkes.be/en/0823558209/dr-leroux-oogarts-dr-ector-cardioloog. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr.Leroux, oogarts - Dr.Ector, cardioloog from Herent, company number BE0823558209, closed financial year 2025 with a result of € 739,953 after tax. For that financial year Dr.Leroux, oogarts - Dr.Ector, cardioloog recorded a gross margin of € 1 million and equity of € 3.3 million. Compared with financial year 2024, the result moved from € 655,010 to € 739,953. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 18, 2026.

What it is worth Growing

€ 3.3 million

▲ 17% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 739,953

▲ 13% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1.6 million

▲ 226% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 263,746 paid out

36 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 16,247

▲ 17% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 6 years to go

€ 65,014

▼ 14% vs 2024

€ 10,477 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 1,647

▼ 15% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 22,461

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 801,730 Gross margin 2022: € 801,730 First fiscal year in the series	€ 868,930 Gross margin 2023: € 868,930 ▲ 8% vs 2022 (€ 801,730) Favourable step	€ 1,000,703 Gross margin 2024: € 1,000,703 ▲ 15% vs 2023 (€ 868,930) Favourable step	€ 1,031,489 Gross margin 2025: € 1,031,489 ▲ 3% vs 2024 (€ 1,000,703) Favourable step	▲ 3%
Profit after taxes	€ 424,291 Profit after taxes 2022: € 424,291 First fiscal year in the series	€ 557,141 Profit after taxes 2023: € 557,141 ▲ 31% vs 2022 (€ 424,291) Favourable step	€ 655,010 Profit after taxes 2024: € 655,010 ▲ 18% vs 2023 (€ 557,141) Favourable step	€ 739,953 Profit after taxes 2025: € 739,953 ▲ 13% vs 2024 (€ 655,010) Favourable step	▲ 13%
Equity	€ 2,110,408 Equity 2022: € 2,110,408 First fiscal year in the series	€ 2,393,288 Equity 2023: € 2,393,288 ▲ 13% vs 2022 (€ 2,110,408) Favourable step	€ 2,853,949 Equity 2024: € 2,853,949 ▲ 19% vs 2023 (€ 2,393,288) Favourable step	€ 3,330,156 Equity 2025: € 3,330,156 ▲ 17% vs 2024 (€ 2,853,949) Favourable step	▲ 17%
Total debts	€ 107,971 Total debts 2022: € 107,971 First fiscal year in the series	€ 116,737 Total debts 2023: € 116,737 ▲ 8% vs 2022 (€ 107,971) Unfavourable step	€ 125,650 Total debts 2024: € 125,650 ▲ 8% vs 2023 (€ 116,737) Unfavourable step	€ 97,059 Total debts 2025: € 97,059 ▼ 23% vs 2024 (€ 125,650) Favourable step	▼ 23%
Cash	€ 973,718 Cash 2022: € 973,718 First fiscal year in the series	€ 799,962 Cash 2023: € 799,962 ▼ 18% vs 2022 (€ 973,718) Unfavourable step	€ 492,951 Cash 2024: € 492,951 ▼ 38% vs 2023 (€ 799,962) Unfavourable step	€ 1,604,606 Cash 2025: € 1,604,606 ▲ 226% vs 2024 (€ 492,951) Favourable step	▲ 226%
Land & buildings	€ 825,544 Land & buildings 2022: € 825,544 First fiscal year in the series	€ 786,224 Land & buildings 2023: € 786,224 ▼ 5% vs 2022 (€ 825,544) Unchanged	€ 733,592 Land & buildings 2024: € 733,592 ▼ 7% vs 2023 (€ 786,224) Unchanged	€ 680,960 Land & buildings 2025: € 680,960 ▼ 7% vs 2024 (€ 733,592) Unchanged	▼ 7%
Retained profit	€ 2,098,008 Retained profit 2022: € 2,098,008 First fiscal year in the series	€ 2,379,028 Retained profit 2023: € 2,379,028 ▲ 13% vs 2022 (€ 2,098,008) Favourable step	€ 2,839,689 Retained profit 2024: € 2,839,689 ▲ 19% vs 2023 (€ 2,379,028) Favourable step	€ 3,315,896 Retained profit 2025: € 3,315,896 ▲ 17% vs 2024 (€ 2,839,689) Favourable step	▲ 17%
Dividend	€ 185,149 Dividend 2022: € 185,149 First fiscal year in the series	€ 274,262 Dividend 2023: € 274,262 ▲ 48% vs 2022 (€ 185,149) Unchanged	€ 194,349 Dividend 2024: € 194,349 ▼ 29% vs 2023 (€ 274,262) Unchanged	€ 263,746 Dividend 2025: € 263,746 ▲ 36% vs 2024 (€ 194,349) Unchanged	▲ 36%
Bank debt	€ 95,956 Bank debt 2022: € 95,956 First fiscal year in the series	€ 85,722 Bank debt 2023: € 85,722 ▼ 11% vs 2022 (€ 95,956) Favourable step	€ 75,409 Bank debt 2024: € 75,409 ▼ 12% vs 2023 (€ 85,722) Favourable step	€ 65,014 Bank debt 2025: € 65,014 ▼ 14% vs 2024 (€ 75,409) Favourable step	▼ 14%
Balance sheet total	€ 2,218,380 Balance sheet total 2022: € 2,218,380 First fiscal year in the series	€ 2,510,024 Balance sheet total 2023: € 2,510,024 ▲ 13% vs 2022 (€ 2,218,380) Unchanged	€ 2,979,599 Balance sheet total 2024: € 2,979,599 ▲ 19% vs 2023 (€ 2,510,024) Unchanged	€ 3,427,215 Balance sheet total 2025: € 3,427,215 ▲ 15% vs 2024 (€ 2,979,599) Unchanged	▲ 15%

By gross margin, Dr.Leroux, oogarts - Dr.Ector, cardioloog ranks 1st of 32 companies with main activity “Activiteiten van medisch specialisten” in Herent that publish figures (fiscal year 2025).

Key figures of Dr.Leroux, oogarts - Dr.Ector, cardioloog, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

Ask about Dr.Leroux, oogarts - Dr.Ector, cardioloog the way you would ask their accountant.

Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.

Connect ChatGPT or Claude for free

ChatGPT
Claude

Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.

What happened to Dr.Leroux, oogarts - Dr.Ector, cardioloog?

What happened at Dr.Leroux, oogarts - Dr.Ector, cardioloog in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 18, 2026 New annual accounts for financial year 2025: profit of € 739,953 (▲ 13% vs 2024). Source: NBB ↗
Feb 26, 2010 New establishment in Herent. KBO
Feb 26, 2010 Start of the company according to the CBE. KBO

In short

From € 424,291 profit in 2022 to € 739,953 profit in 2025.

Paid € 1.1 million in corporate taxes since 2022.

Best year ever: 2025, with € 739,953 profit.

Paid out € 917,506 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

KATHLEEN LEROUX 50%

BAVO ECTOR 50%

Dr.Leroux, oogarts - Dr.Ector, cardioloog

OKIO OOGKLINIEK 33.3%

Behind Dr.Leroux, oogarts - Dr.Ector, cardioloog are Kathleen Leroux and Bavo Ector. The shares are held by KATHLEEN LEROUX (50%) and BAVO ECTOR (50%). It owns 33.3% of OKIO OOGKLINIEK itself.